KRISTIN PICKARD: Open Payments
NPI 1326162926 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 63 payments from 18 companies in 2025. Trend: 2023 $361 · 2024 $1,275 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 18 | $287 |
| Novartis Pharmaceuticals Corporation | 15 | $256 |
| ABBVIE INC. | 7 | $143 |
| Genmab U.S., Inc. | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Genentech USA, Inc. | 2 | $41 |
| JAZZ PHARMACEUTICALS INC. | 2 | $41 |
| SOBI, INC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Lilly USA, LLC | 2 | $32 |
Products named: Enhertu, EPKINLY, SCEMBLIX, DATROWAY, VENCLEXTA, PLUVICTO, Fabhalta, KISQALI.
Industry payments across OK — which companies pay providers there.
